Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C226
http://purl.obolibrary.org/obo/NCIT_C226
|
|---|---|
| Preferred Name | Eflornithine |
| Definitions |
A difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. This agent has been shown to induce apoptosis in leiomyoma cells. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. This agent has been shown to induce apoptosis in leiomyoma cells. (NCI04) |
|---|---|
| prefLabel | Eflornithine
|
| label | Eflornithine
|
| Has_Salt_Form | |
| CHEBI_ID | CHEBI:41948
|
| PDQ_Closed_Trial_Search_ID | 39754
|
| code | C226
|
| Has_Target | |
| prefixIRI | NCIT:C226
|
| in_subset |
See more
See less
|
| Display_Name | Eflornithine
|
| Preferred_Name | Eflornithine
|
| FDA_UNII_Code | ZQN1G5V6SR
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C6H12F2N2O2
|
| Maps_To | Eflornithine
|
| CAS_Registry |
67037-37-0
70052-12-9
|
| NCI_Drug_Dictionary_ID | 39754
|
| Legacy Concept Name | Eflornithine
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the prevention of cancer. It belongs to the family of drugs called antiprotozoals.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 39754
|
| Accepted_Therapeutic_Use_For | Hirsutism, facial; Trypanosoma brucei gambiense (sleeping sickness) infection
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0002260
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |